EN
TradingView
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Sign Out Upgrade Upgrade now 30-day Free Trial Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1
Markets Poland Stocks Health Technology Pharmaceuticals: Other

BIOMEDLUB
BML GPW

BML
BIOMEDLUB GPW
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Financials Technicals

BML Stock Chart

Ideas

Videos only
Antibody medicine move
BML
, 1D
Long
BML: Antibody medicine move

Biomedlub should soon announce that thier medicine for COVID-19 passed tests. We can see consolidation on chart.

BIOMEDLUB BML
BML
, 1W
Long
BML: BIOMEDLUB BML

Raising sequence is evolving, (iii)/5 wave to occur now.

BIOMED
BML
, 60
Long
BML: BIOMED

Currently downtrend of BIOMED Price Targets: 14,50zzł - 0.618Fib and GANN support 12zł Support area Waiting for green signal from SMASRI96

BML BIOMEDLUB
BML
, 60
Long
BML: BML BIOMEDLUB

5th wave to come...

BIOMEDLUB BML
BML
, 60
Long
BML: BIOMEDLUB BML

(5) wave to go now.

Biomedlub BML
BML
, 60
Long
BML: Biomedlub BML

Another round to 18-20 PLN after today's correction.

BIOMED
BML
, 60
Long
BML: BIOMED

General correction in terms of price is over, we shall see rally to lower rectangle at least.

Cofniecie i do flagi. Najbliższy cel 17 PLN
BML
, 1D
BML: Cofniecie i do flagi. Najbliższy cel 17 PLN

Wejście do flagi po korekcyjnej fali Elliota. Możliwość tradowania w ramach flagi. Uwaga, pilnować wyjścia.

Biomed
BML
, 60
BML: Biomed

How I see it now

Tirangle on Biomed
BML
, 1D
BML: Tirangle on Biomed

In my opinion it will break up, but comfirmation it's necessary

BIOMEDLUB BML
BML
, 240
BML: BIOMEDLUB BML

.....................

BIOMEDLUB
BML
, 240
Long
BML: BIOMEDLUB

...................

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. Its products include prescription and over-the-counter medicines, medical devices, and laboratory reagents. The company was founded on December 4, 1944 and is headquartered in Lublin, Poland.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out
Upgrade Upgrade now 30-day Free Trial Start free trial Upgrade plan Pay nothing extra Upgrade early Get 6 months free Use last chance Get a month for $1